Skip to main content
Anthony Faugno IV, MD, Pulmonology, Boston, MA

Anthony J Faugno IV MD

Critical Care Medicine, Pulmonary Vascular Medicine


Pulmonary Critical Care Fellow PGY6

Join to View Full Profile
  • 800 Washington StreetBoston, MA 02111

  • Phone+1 617-636-5000

Dr. Faugno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Anthony Faugno is a pulmonologist in Boston, MA and is affiliated with Tufts Medical Center. He received his medical degree from Drexel University College of Medicine and has been in practice 5 years. He specializes in critical care medicine and pulmonary vascular medicine.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2018
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 2012 - 2015
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2012

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19  
    Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine

Press Mentions

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineDecember 30th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: